Cxcl12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and cxcr4 positive circulating tumoral cells in lung draining venous blood

European Journal of Cardio-thoracic Surgery

Volumn 41, Issue 2, 2012, Pages 368-375

  Franco, Renato ^a   Pirozzi, Giuseppe ^a   Scala, Stefania ^b   Cantile, Monica ^a   Scognamiglio, Giosuè ^a   Camerlingo, Rosalba ^a   Botti, Gerardo ^a   Rocco, Gaetano ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Instituto Pascale   (Italy)

Author keywords

Chemokine receptors; Lung cancer; Microvascular density.

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; CYTOKERATIN; CHEMOKINE RECEPTOR CXCR; CXCL12 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN; CXCR7 PROTEIN, HUMAN; KERATIN; STROMAL CELL DERIVED FACTOR 1; TUMOR MARKER; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY VEIN; TUMOR CELL; VENOUS BLOOD; BLOOD; CANCER INVASION; CANCER STAGING; EPIDEMIOLOGY; LUNG TUMOR; METABOLISM; METASTASIS; MICROVASCULATURE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TUMOR EMBOLISM; VASCULARIZATION;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOKINE CXCL12; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; KERATINS; LUNG NEOPLASMS; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; RECEPTORS, CXCR; RECEPTORS, CXCR4; TUMOR MARKERS, BIOLOGICAL;

EID: 84860321876     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2011.05.009     Document Type: Article

References (25)

1. Stein-Werblowsky R. The haematogenous spread of tumor: a prevental process. J Cancer Res Clin Oncol 1983;105:158-611.
2. Brechot JM, Chevret S, Charpentier MC. Blood vessel and lymphatic vessel invasion in resected non-small cell lung carcinoma: correlation with TNM stage and disease free and overall survival. Cancer 1996;78: 2111-8.
3. Suzuki K, Nagai K, Yoshida J, Nishimura M, Nishiwaki Y. Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non-small cell lung carcinoma. Ann Thorac Surg 2001;72:352-6.
4. Tsuchiya T, Hashizume S, Akamine S, Muraoka M, Honda S, Tsuji K, Urabe S, Hayashi T, Yamasaki N, Nagayasu T. Upstaging by vessel invasion improves the pathology staging system of non-small cell lung cancer. Chest 2007;132:170-7.
5. Sienel W, Seen-Hibler R, Mutschler W, Pantel K, Passlick B. Tumour cells in the tumour draining vein of patients with non-small cell lung cancer: detection rate and clinical significance. Eur J Cardiothorac Surg 2003;23: 451-6.
6. Teicher Beverly A, Fricker Simon P. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 2010;16:2927-31.
7. Gangadhar T, Nandi S, Salgia R. The role of chemokine receptor CXCR4 in lung cancer. Cancer Biol Ther 2010;6:409-16.
8. Wagner PL, Hyjek E, Vazquez MF, Meherally D, Liu YF, Chadwick PA, Rengifo T, Sica GL, Port JL, Lee PC, Paul S, Altorki NK, Saqi A. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival. J Thorac Cardiovasc Surg 2009;137:615-21.
9. Reckamp KL, Figlin RA, Burdick MD, Dubinett SM, Elashoff RM, Strieter RM. CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer. BMC Cancer 2009;29:9-213.
10. Kijowski J, Baj-Krzyworzeka M, Majka M, Reca R, Marquez LA,Christofidou-Solomidou M, Janowska-Wieczorek A, Ratajczak MZ. The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. Stem Cells 2001;5:453-66.
11. Ottaiano A, Franco R, Aiello Talamanca A, Liguori G, Tatangelo F, Delrio P, Nasti G, Barletta E, Facchini G, Daniele B, Di Blasi A, Napolitano M, Ierano C, Calemma R, Leonardi E, Albino V, De Angelis V, Falanga M, Boccia V, Capuozzo M, Parisi V, Botti G, Castello G, Vincenzo Iaffaioli R, Scala S. Overexpression of both CXC chemokine receptor 4 and vascularendothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Clin Cancer Res 2006;12:2795-803.
12. Franco R, Botti G, Mascolo M, Loquercio G, Liguori G, Ilardi G, Losito S, La Mura A, Calemma R, Ierano C, Bryce J, D'Alterio C, Scala S. CXCR4-CXCL12 and VEGF correlate to uveal melanoma progression. Front Biosci 2010;2:13-21.
13. Wang Q, Diao X, Sun J, Chen Z. Regulation of VEGF, MMP-9, and metastasis by CXCR4 in a prostate cancer cell line. Cell Biol Int 2011;35: 897-904.
14. Miao Z, Luker KE, Summers BC, Berahovich R, Bhojani MS, Rehemtulla A, Kleer CG, Essner JJ, Nasevicius A, Luker GD, Howard MC, Schall TJ. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 2007;104:15735-40.
15. Dango S, Sienel W, Schreiber M, Stremmel C, Kirschbaum A, Pantel K, Passlick B. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer. Lung Cancer 2008;60: 426-33.
16. Kubuschok B, Passlick B, Izbicki JR, Thetter O, Pantel K. Disseminate tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin Oncol 1999;17: 19-24.
17. Yamashita JI, Kurusu Y, Fujino N, Saisyoji T, Ogawa M. Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination. J Thorac Cardiovasc Surg 2000;119:899-905.
18. Ge MJ, Shi D, Wu QC, Wang M, Li LB. Observation of circulating tumour cells in patients with non-small cell lung cancer by real-time fluorescent quantitative reverse transcriptase-polymerase chain reaction in peroperative period. J Cancer Res Clin Oncol 2006;132:248-56.
19. Hou JM, Krebs M, Ward T, Sloane R, Priest L, Ranson M, Dive C. Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol 2011;178:989-96.
20. Franco R, Cantile M, Scala S, Catalano E, Cerrone M, Scognamiglio G, Pinto A, Chiofalo MG, Caracéo C, Anniciello AM, Abbruzzese A, Caraglia M, Botti G. Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome. Cancer Biol Ther 2010;9:423-9.
21. Iwakiri S, Mino N, Takahashi T, Sonobe M, Nagai S, Okubo K, Wada H, Date H, Miyahara R. Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer. Cancer 2009;115:2580-93.
22. Belperio JA, Phillips RJ, Burdick MD, Lutz M, Keane M, Strieter R. The SDF-1/CXCL 12/CXCR4 biological axis in non-small cell lung cancer metastases. Chest 2004;125:156S.
23. D'Alterio C, Consales C, Polimeno M, Franco R, Cindolo L, Portella L, Cioffi M, Calemma R, Marra L, Claudio L, Perdona S, Pignata S, Facchini G, Carteni G, Longo N, Pucci L, Ottaiano A, Costantini S, Castello G, Scala S. Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer. Curr Cancer Drug Targets 2010;10:772-81.
24. Macchiarini P, Fontanini G, Hardin MJ, Squartini F, Angeletti CA. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 1992;340:145-6.
25. Liao M, Wang H, Lin Z, Feng J, Zhu D. Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer. Lung Cancer 2001;33:125-32.